TC BioPharm (Holdings) plc Annual Operating Income (Loss) in GBP from 2022 to 2023

Taxonomy & unit
us-gaap: GBP
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
TC BioPharm (Holdings) plc quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
  • TC BioPharm (Holdings) plc Operating Income (Loss) for the quarter ending March 31, 2024 was -£3.44M, a 17.4% increase year-over-year.
  • TC BioPharm (Holdings) plc annual Operating Income (Loss) for 2023 was -£14.2M, a 17.8% decline from 2022.
Operating Income (Loss), Annual (GBP)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -14.2M -2.16M -17.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -12.1M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.